Thursday, November 28, 2013

Cabergoline in solution tested against Tablet form.

Pharmacodynamics and relative bioavailability of cabergoline tablets vs solution in healthy volunteers.


Persiani S, Sassolas G, Piscitelli G, Bizollon CA, Poggesi I, Pianezzola E, Edwards DM, Strolin Benedetti M.

Source

Pharmacia-Farmitalia Carlo Erba R&D, Nerviano (MI), Italy.

Abstract

The effect of formulation on the urinary pharmacokinetics, pharmacodynamics, and relative bioavailability of cabergoline was investigated. Twelve healthy female volunteers, aged 23-35 years, were treated, according to an open, randomized, crossover design, with cabergoline (1-mg single oral dose) both as tablets and as a solution. The two administrations were separated by a 4-week wash-out period. Cabergoline and prolactin were measured in urine and plasma, respectively, by specific radioimmunoassays. Blood samples were collected before and up to 30 days after dosing. Urine was collected before and up to 8 days after dosing. Cabergoline elimination half-lives calculated from urinary data were 68 and 63 h after administration of the tablets and the solution, respectively. Urinary excretion of unchanged cabergoline accounted, on average, for 1.92% (range, 0.14-3.26) and 1.80% (range, 0.67-3.09) of the dose after administration of the tablets and the aqueous solution, respectively. Relative bioavailability of tablets vs solution was 99% (geometric mean with the 90% confidence intervals of 68-144%). Prolactin levels in 10 out of 12 subjects fell below the detection limit of the assay (1.5 micrograms/L) after both treatments. The mean maximum prolactin decrease (ca. 70%) was achieved by 2 or 3 h after dosing; the effect persisted up to 9 days, being completely exhausted 23-28 days after dosing. The analysis of variance performed on the pharmacodynamic effects of the two cabergoline formulations indicated that the percent decreases of plasma prolactin levels were not significantly different for tablets and solution. These results indicate that the pharmacodynamics and relative bioavailability of cabergoline are not influenced by formulation, as tablets or solution.


PMID: 7884663 [PubMed - indexed for MEDLINE]


Wednesday, November 27, 2013

Clenbuterol is on it's way!

Soon www.madisonjamesresearchchems.com will be offer clenbuterol!

This coming week we will have 30ml bottles of clenbuterol. 
You will be able to buy clenbuterol this coming week. Like the Dec 4 or 5th. 
The clenbuterol will be 200mcg per ml in 30ml bottles

All clenbuterol bottle will come with a dropper or an oral syringe to measure the dose for your research needs. 

Sunday, November 17, 2013

Buy Follistatin 344 | buy peptides

Are you looking to Buy peptides Follistatin 344 ? 
Look no more. 
We offer the best in quality peptides for your research needs. 
We offer Follistatin 344, igf-1 lr3, ghrp-6, ghrp-2 and many more peptides. 

Our customer services and fast shipping is the best around. 

So if your looking to Buy peptides online we have what you need. 




Tuesday, November 12, 2013

Buy cabergoline online | madisonjamesresearch.com

Looking to Buy research chemicals cabergoline online in the USA?
If your looking for cabergoline in the USA, look no more

www.madisonjamesresearch.com has what your looking for, for all your research chemicals needs. We can have your research chemical cabergoline to your door in no time. 



Saturday, November 9, 2013

Research chemical tamoxifen citrate

Looking to Buy tamoxifen citrate online from a research company with the highest quality?
Look no more. www.MadisonJamesResearch.com has all your research chemical needs. From tadalafil, clomiphene, sildenafil and of course tamoxifen citrate. Are tamoxifen citrate is 25mg and 30 ml. Plenty for your research needs.

So if your looking to Buy research chemical tamoxifen citrate come check us out.